Literature DB >> 30539453

An Introduction to the Performance of Immunohistochemistry.

Shino Magaki1, Seyed A Hojat1, Bowen Wei1, Alexandra So1, William H Yong2,3,4.   

Abstract

Immunohistochemistry (IHC) is a powerful technique that exploits the specific binding between an antibody and antigen to detect and localize specific antigens in cells and tissue, most commonly detected and examined with the light microscope. A standard tool in many fields in the research setting, IHC has become an essential ancillary technique in clinical diagnostics in anatomic pathology (Lin F, Chen Z. Arch Pathol Lab Med 138:1564-1577, 2014) with the advent of antigen retrieval methods allowing it to be performed conveniently on formalin fixed paraffin embedded (FFPE) tissue (Taylor CR, Shi S-R, Barr NJ. Techniques of immunohistochemistry: principles, pitfalls, and standardization. In: Dabbs DJ (ed) Diagnostic immunohistochemistry: theranostic and genomic applications, 3rd edn. Saunders, Philadelphia, 2010; Shi SR, Key ME, Kalra KL. J Histochem Cytochem 39:741-748, 1991) and automated methods for high volume processing with reproducibility (Prichard J, Hicks D, Hammond E. Automated immunohistochemistry overview. In: Fan L, Jeffrey P (eds) Handbook of practical immunohistochemistry: frequently asked questions, 2nd edn. Springer, New York, 2015). IHC is frequently utilized to assist in the classification of neoplasms, determination of a metastatic tumor's site of origin and detection of tiny foci of tumor cells inconspicuous on routine hematoxylin and eosin (H&E) staining. Furthermore, it is increasingly being used to provide predictive and prognostic information, such as in testing for HER2 amplification in breast cancer (Wolff AC, Hammond MEH, Hicks DG et al. Arch Pathol Lab Med 138:241-256, 2014) in addition to serving as surrogate markers for molecular alterations in neoplasms, including IDH1 and ATRX mutations in brain tumors (Appin CL, Brat DJ. Mol Aspects Med. 45:87-96, 2015). In this chapter we describe the basic methods of immunohistochemical staining which has become an essential tool in the daily practice of anatomic pathology worldwide.

Entities:  

Keywords:  Antibodies; Antigen retrieval; Antigens; Immunohistochemistry; Light microscopy

Mesh:

Substances:

Year:  2019        PMID: 30539453      PMCID: PMC6749998          DOI: 10.1007/978-1-4939-8935-5_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

1.  Assessment of Lung Eosinophils In Situ Using Immunohistological Staining.

Authors:  Christopher D Nazaroff; William E LeSuer; Mia Y Masuda; Grace Pyon; Paige Lacy; Elizabeth A Jacobsen
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders.

Authors:  Daniela Navarro; Ani Gasparyan; Francisco Navarrete; Abraham B Torregrosa; Gabriel Rubio; Marta Marín-Mayor; Gabriela B Acosta; Maria Salud Garcia-Gutiérrez; Jorge Manzanares
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  Towards 'end-to-end' analysis and understanding of biological timecourse data.

Authors:  Siddhartha G Jena; Alexander G Goglia; Barbara E Engelhardt
Journal:  Biochem J       Date:  2022-06-17       Impact factor: 3.766

4.  Utility of CD138/syndecan-1 immunohistochemistry for localization of plasmacytes is tissue-dependent in B6 mice.

Authors:  David K Meyerholz; Mariah R Leidinger; J Adam Goeken; Thomas R Businga; Allison Akers; Sebastian Vizuett; Courtney A Kaemmer; Jordan L Kohlmeyer; Rebecca D Dodd; Dawn E Quelle
Journal:  BMC Res Notes       Date:  2022-06-25

5.  Novel PGK1 determines SKP2-dependent AR stability and reprograms granular cell glucose metabolism facilitating ovulation dysfunction.

Authors:  Xia Liu; Changfa Sun; Kexin Zou; Cheng Li; Xiaojun Chen; Hangchao Gu; Zhiyang Zhou; Zuwei Yang; Yaoyao Tu; Ningxin Qin; Yiran Zhao; Yimei Wu; Yicong Meng; Guolian Ding; Xinmei Liu; Jianzhong Sheng; Chuanjin Yu; Hefeng Huang
Journal:  EBioMedicine       Date:  2020-10-21       Impact factor: 8.143

6.  Clinical Stratification of High-Grade Ovarian Serous Carcinoma Using a Panel of Six Biomarkers.

Authors:  Swapnil C Kamble; Arijit Sen; Rahul D Dhake; Aparna N Joshi; Divya Midha; Sharmila A Bapat
Journal:  J Clin Med       Date:  2019-03-08       Impact factor: 4.241

7.  Retinal Spheroids and Axon Pathology Identified in Amyotrophic Lateral Sclerosis.

Authors:  Kieran Sharma; Maryam Amin Mohammed Amin; Neeru Gupta; Lorne Zinman; Xun Zhou; Hyacinth Irving; Yeni Yücel
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

8.  Integrated Analysis of Key Genes and Pathways Involved in Fetal Growth Restriction and Their Associations With the Dysregulation of the Maternal Immune System.

Authors:  Xue Wang; Hong Zhu; Lei Lei; Yang Zhang; Chao Tang; Jia-Xing Wu; Jie-Ru Zhou; Xi-Rong Xiao
Journal:  Front Genet       Date:  2021-01-08       Impact factor: 4.599

9.  Myosin light chain kinase is a potential target for hypopharyngeal cancer treatment.

Authors:  Feng Cao; Le Zhu; Jing Zhang; Pawin Pongkorpsakol; Wei-Ting Kuo; Jerrold R Turner; Qing Zhou; Yuan Wang; Feihu Chen; Yehai Liu; Li Zuo
Journal:  Biomed Pharmacother       Date:  2020-09-10       Impact factor: 6.529

10.  Elevation of CD40/CD40L Inflammatory Pathway Molecules in Carotid Plaques from Moderate-and-Severe Obstructive Sleep Apnea Patients.

Authors:  Ewa Migacz; Wioletta Olejarz; Alicja Głuszko; Katarzyna Bednarek-Rajewska; Robert Proczka; David F Smith; Stacey L Ishman; Wojciech Kukwa
Journal:  Diagnostics (Basel)       Date:  2021-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.